首页> 外文会议>World congress on medical physics and biomedical engineering >Dedicated treatment planning system for the evaluation of the doses delivered to the whole patient body during radiotherapy
【24h】

Dedicated treatment planning system for the evaluation of the doses delivered to the whole patient body during radiotherapy

机译:用于评估放疗过程中递送给整个患者体内的剂量的专用治疗计划系统

获取原文
获取外文期刊封面目录资料

摘要

Describe the principles and report the preliminary results on dose distributions obtained with a new generation of treatment planning system (TPS) designed to provide, in addition to the dose distributions within the target-volumes, the magnitude of the doses to distant healthy tissues in the course of common radiotherapy procedures. The system is made of (1) a library of adjustable whole-body patient models in radiotherapy treatment position, allowing different patient anatomies to be simulated, (2) a global-beam model allowing the dosimetric data of the irradiation beams to be extended to the whole body and (3) a TPS modified to handle the two first modules in order to produce the dose distributions within the target-volumes and in any organ at distance. Our preliminary results indicate that in an adult male patient treated by radiotherapy for Hodgkin disease using two opposed 6 MV photon beams, the mean doses to distant organs are: 0.9 % of the target volume dose for the pituitary gland, 0.40% to 3.4% for the kidneys, 0.43% for the prostate, and at larger distance, 0.07% and 0.02 % at the level of the knees and the feet respectively. Although the development of our system is still in progress, the preliminary results are encouraging. This systematic evaluation of the low doses delivered at distance of the target-volumes is a basic requirement for prospective studies of long-term risks of modern radiotherapy procedures.
机译:描述的原则和报告与设计提供新一代的治疗计划系统(TPS)中获得的剂量分布的初步结果,除了目标卷内的剂量分布,剂量在遥远的健康组织的大小当然,普通放疗过程。该系统是由(1)要被模拟在放射治疗位置可调节全身患者模型,允许不同的患者解剖结构的文库,(2)全球波束模型允许照射的剂量测定数据束被扩展到整个身体和(3)一个TPS修改以处理,以所述目标体积内,并且在距离的任何器官产生的剂量分布的两个第一模块。我们的初步结果表明,通过放疗使用两个霍奇金病治疗的成年男性患者反对6 MV光子束,平均剂量远处器官有:靶区剂量脑垂体,0.40%至3.4%,为0.9%肾脏,0.43%的前列腺癌,并且在较大的距离,0.07%和分别在膝盖和脚的水平为0.02%。虽然我们的系统的开发仍在进行中,初步结果令人鼓舞。在目标卷的距离交付的低剂量的这一系统的评价是的现代放疗过程的长期风险的前瞻性研究的基本要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号